Used in research and development for Alzheimer’s disease diagnostics and therapeutics due to its specific binding to amyloid beta peptides. It serves as a critical tool in immunoassays to detect and quantify amyloid beta aggregates in biological samples. Commonly employed in ELISA, Western blot, and immunohistochemistry to study plaque formation in brain tissue. Supports validation of new anti-amyloid compounds and is widely used in preclinical studies to assess target engagement and efficacy of experimental treatments. Also utilized as a standard in quality control for antibody-based assays targeting amyloid pathology.